Renowned psychiatrist Charles Nemeroff stepped down from his position as chairman of the psychiatry department at Emory University on Friday (Oct. 3) amid accusations that he's failed to disclose hundreds of thousands of dollars in pharmaceutical company payouts while receiving millions of dollars in federal research funding. Nemeroff's apparent lack of disclosure is being probed by Senator linkurl:Charles Grassley;http://www.the-scientist.com/blog/display/54832/ (R-IA) from his perch as the ranking Republican in the Senate Finance Committee. Following the psychiatrist's departure, Emory University officials told the linkurl:__Atlanta Journal-Constitution__;http://www.ajc.com/metro/content/metro/dekalb/stories/2008/10/04/Emory_professor_investigation.html over the weekend that the school is launching its own investigation into Nemeroff's activities. In a linkurl:letter;http://frwebgate6.access.gpo.gov/cgi-bin/PDFgate.cgi?WAISdocID=310197337729+0+1+0&WAISaction=retrieve sent to Emory president James Wagner last week, Grassley outlined discrepancies in Nemeroff's disclosure reports to the university. From 2003 - 2008, as Nemeroff served as principal investigator on a multi-million dollar grant from the National Institutes of Health to study five GlaxoSmithKline (GSK) antidepressants, the psychiatrist was paid -...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?